Timothy Godfrey

Systematic review, and meta-analysis of steroid-sparing effect, of biologic agents in randomized, placebo-controlled phase 3 trials for systemic lupus erythematosus

Shereen Oon, Molla Huq, Timothy Godfrey, Mandana Nikpour

Journal article  |  2018  |  SEMINARS IN ARTHRITIS AND RHEUMATISM

OBJECTIVES: To systematically review, and conduct a meta-analysis of steroid-sparing effect in, phase 3 randomized, placebo-contro..

Does expert opinion match the operational definition of the Lupus Low Disease Activity State (LLDAS)? A case-based construct validity study

Vera Golder, Molla Huq, Kate Franklyn, Alicia Calderone, Aisha Lateef, Chak Sing Lau, Alfred Lok Hang Lee, Sandra Teresa V Navarra, Timothy Godfrey, Shereen Oon, Alberta Yik Bun Hoi, Eric Francis Morand, Mandana Nikpour

Journal article  |  2017  |  SEMINARS IN ARTHRITIS AND RHEUMATISM

OBJECTIVE: To evaluate the construct validity of the Lupus Low Disease Activity State (LLDAS), a treatment target in systemic lupu..

Adult Orbital Xanthogranuloma Successfully Treated with Rituximab

Khami Satchi, Alan A McNab, Timothy Godfrey, H Miles Prince

Journal article  |  2014  |  OPHTHALMOLOGY

Hydroxychloroquine in lupus: emerging evidence supporting multiple beneficial effects

C Tang, T Godfrey, R Stawell, M Nikpour

Journal article  |  2012  |  INTERNAL MEDICINE JOURNAL

Due to multiple beneficial effects, including control of disease activity, reduction in cardiovascular events and improved surviva..